A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery

Alexander Iribarne1, Rachel Easterwood, Mark J Russo

  • 1Division of Cardiothoracic Surgery, Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Abstract

Insights

Minimally invasive mitral valve surgery (MIMVS) offers a cost-saving strategy compared to traditional sternotomy (ST) for mitral valve surgery (MVS). MIMVS demonstrates equivalent efficacy with lower hospital costs and reduced readmissions, making it a favorable approach.

Area of Science:

  • Cardiovascular Surgery
  • Health Economics

Background:

  • Mitral valve surgery (MVS) traditionally involves sternotomy (ST), a procedure with significant associated costs.
  • Minimally invasive (MI) approaches to MVS have emerged, necessitating a comparison of their cost-effectiveness.

Purpose of the Study:

  • To compare the cost and effectiveness of minimally invasive mitral valve surgery (MIMVS) versus traditional sternotomy (ST) for MVS.
  • To identify specific cost drivers and clinical outcomes associated with each surgical approach.

Main Methods:

  • A retrospective analysis of 847 patients undergoing isolated MVS between 2003 and 2008.
  • Propensity matching of 434 patients (217 pairs) based on 22 clinical variables.
  • Analysis of direct and indirect hospital costs, morbidity, mortality, discharge disposition, readmissions, and reoperation rates.

Main Results:

  • MIMVS was associated with significantly lower mean total hospital costs ($9054 ± $3302 reduction, P=.006) compared to ST.
  • Cost reductions in MIMVS were observed in cardiac imaging, laboratory tests, nursing care, and radiology.
  • No significant differences in morbidity or long-term survival were found between MIMVS and ST.
  • MI patients had higher rates of discharge home without nursing services (P=.018), while ST patients had higher 1-year readmission rates (P=.023).

Conclusions:

  • Minimally invasive mitral valve surgery (MIMVS) is a cost-saving strategy for MVS.
  • MIMVS demonstrates equivalent efficacy to traditional sternotomy (ST) across various clinical measures.
  • The findings support MIMVS as a preferred approach due to its economic benefits and comparable patient outcomes.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...